Demo Sign up Log In

Syndax Pharmaceuticals Inc (SNDX)

Cash Conversion Ratio

0.61×

Quarterly · Period ending: Jun 30, 2026

SNDX Cash Conversion Ratio

Latest reported0.61×period endingJun 30, 2026

Latest reported0.61×period endingJun 30, 2026

SNDX Quarterly Cash Conversion Ratio (0.33× → 0.61×)

Latest values, visible window

High-resolution chart · PNG

SNDX cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Syndax Pharmaceuticals Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Jun 30, 2026	0.6141×
Mar 31, 2026	1.1798×
Dec 31, 2025	1.0225×
Sep 30, 2025	1.1639×
Jun 30, 2025	1.222×
Mar 31, 2025	1.1216×
Dec 31, 2024	0.6094×
Sep 30, 2024	0.7408×
Jun 30, 2024	1.0526×
Dec 31, 2021	1.0456×
Sep 30, 2021	1.2086×
Jun 30, 2021	1.0495×
Mar 31, 2021	0.8148×
Dec 31, 2020	0.7654×
Sep 30, 2020	0.8953×
Jun 30, 2020	1.2547×
Mar 31, 2020	1.0452×
Dec 31, 2019	0.9091×
Sep 30, 2019	0.6648×
Jun 30, 2019	0.8397×
Mar 31, 2019	1.1768×
Dec 31, 2018	0.7993×
Sep 30, 2018	1.0652×
Jun 30, 2018	0.8239×
Mar 31, 2018	1.0333×
Dec 31, 2017	0.6681×
Sep 30, 2017	0.6776×
Jun 30, 2017	0.8652×
Mar 31, 2017	0.9766×
Dec 31, 2016	0.9631×
Sep 30, 2016	0.7685×
Jun 30, 2016	0.8331×
Mar 31, 2016	0.6327×
Dec 31, 2015	0.822×
Sep 30, 2015	0.672×
Jun 30, 2015	0.6439×
Sep 30, 2014	0.3348×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.